Results for tag: "Tremfya"

Tremfya is a prescription medication used to treat moderate to severe plaque psoriasis in adults. It is a monoclonal antibody that works by blocking the action of a protein called interleukin-23 (IL-23). This protein is involved in the inflammation and overproduction of skin cells that cause psoriasis. Tremfya is administered as an injection under the skin every 8 weeks. The dermatological drug market is a rapidly growing sector of the pharmaceutical industry. Tremfya is one of the newer drugs in this market, and is becoming increasingly popular due to its efficacy and convenience. It is also one of the few drugs that can be used in combination with other treatments, such as topical creams and light therapy. Some of the companies in the Tremfya market include Janssen Pharmaceuticals, AbbVie, and Novartis. Show Less Read more